Replies to post #227907 on Biotech Values

[DewDiligence]

Advance Pharma—(private)—acquires CORV for $0.42/sh cash—a 35% premium to Friday’s close:

https://finance.yahoo.com/news/advanz-pharma-acquire-correvio-110000122.html

The nominal deal value is $76M (including assumption of debt).